Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) 抗体
Our Local Distributor
北京 101111
Quick Overview for Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) 抗体 (ABIN1721485)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 2052-2172, C-Term
-
特异性
- Reacts withhuman, mouse, and rat Cav3.1. Does not cross-react with Cav3.2.
-
纯化方法
- Purified
-
免疫原
- Fusion protein corresponding to aa 2052-2172 (cytoplasmic C-terminus) of mouse Cav3.1 (accession no. NP_001106284.1).
-
亚型
- IgG1
-
-
-
-
应用备注
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 2 μg/mL) IHC(1 - 10 μg/mL)
Positive control: Rat brain membranes -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS, pH 7.4, 50 % glycerol
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Dilute in PBS or medium that is identical to that used in the assay system.
-
储存条件
- -20 °C
-
储存方法
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Cav3.1 Ca2+ Channel
-
背景
-
Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Cav3.1 is a low-voltage activated T-type calcium channel expressed throughout the body. Drugs that block T-type calcium channels are used as antihypertensives and anti-epileptics and possibly in some anesthetics and antipsychotics.
Voltage-dependent T-type calcium channel subunit alpha-1G Cav3.1c NBR13 Voltage-gated calcium channel subunit alpha Cav3.1 Gene name: CACNA1G, KIAA1123 Ca(V)T.1, Cav3.1, NBR13 -
基因ID
- 8913
-
UniProt
- O43497
抗原
-